Alternate Day Versus Daily Oral Iron Therapy in Adolescents
NCT05007899 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2023-09-13
Summary
Iron deficiency anemia affects over half of girls and young women with heavy periods and is the most common cause of anemia worldwide. Most girls with heavy periods who also have iron deficiency anemia are prescribed iron to take by mouth every day by their doctor. There are some studies showing that taking iron every other day may actually help the iron be absorbed into the bloodstream better. This study is trying to compare how taking iron every other day compares to taking iron daily for treatment of anemia.
The goal of this clinical research study is to learn which of the two methods of care will be the best way for girls and young women with iron deficiency anemia to take iron supplementation.
Conditions
- Iron Deficiency Anemia
- Heavy Menstrual Bleeding
- Abnormal Uterine Bleeding
Interventions
- DRUG
-
Ferrous sulfate
Alternate day dosing of ferrous sulfate
Sponsors & Collaborators
-
Baylor College of Medicine
lead OTHER
Principal Investigators
-
Jacquelyn Powers, MD · Baylor College of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 9 Years
- Max Age
- 22 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-12-21
- Primary Completion
- 2022-06-30
- Completion
- 2022-12-22
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women
NCT02683369 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia
NCT05047211 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.
NCT07110935 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial
NCT05358509 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia
NCT04253626 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency
NCT03181451 ·Status: COMPLETED ·Phase: PHASE1
-
Iron Absorption From Tef-injera in Women of Reproductive Age
NCT01687062 ·Status: COMPLETED ·Phase: NA
-
Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement
NCT02957643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Sexual Maturation in β-Thalassemia Major Patients in Assiut University Hospital
NCT03847558 ·Status: UNKNOWN
-
A Test of Iron Malabsorption in Patients With Iron Deficiency Anemia
NCT00399191 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia
NCT05179226 ·Status: RECRUITING ·Phase: PHASE3
-
The Optimization of Bioavailability From Iron Supplements: Study 2
NCT02177851 ·Status: COMPLETED ·Phase: NA
-
Hypoferritinemia Without Anemia Among Reproductive Age Females
NCT06437080 ·Status: COMPLETED ·Phase: NA
-
Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia
NCT04130828 ·Status: COMPLETED ·Phase: PHASE3
-
Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia
NCT00929409 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
NCT00000588 ·Status: COMPLETED ·Phase: PHASE2
-
Iron Therapy in Erythropoietic Protoporphyria
NCT05572125 ·Status: COMPLETED
-
Reproductive Capacity and Iron Burden in Thalassemia
NCT02308904 ·Status: COMPLETED ·Phase: NA
-
Iron Supplementation in Upper Non-variceal Gastrointestinal Bleeding
NCT05060731 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate.
NCT01160198 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.
NCT03188445 ·Status: COMPLETED ·Phase: PHASE4
-
The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females
NCT07199244 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Amino Acid Chelated Iron Versus Ferrous Fumarate in the Treatment of Iron Deficiency Anemia With Pregnancy: Randomized Controlled Trial
NCT03830034 ·Status: UNKNOWN ·Phase: PHASE4
-
Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage
NCT04505514 ·Status: UNKNOWN ·Phase: PHASE4
-
Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women
NCT03212781 ·Status: COMPLETED ·Phase: PHASE3